Timing of radiation for brain tumors under scrutiny in new trial
NCT ID NCT07437820
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving focused radiation before surgery (neoadjuvant) or after surgery (adjuvant) works better to keep brain metastases from coming back. About 68 adults with 1 to 12 brain tumors will be randomly assigned to one of the two groups. Doctors will track tumor regrowth at 6, 12, and 24 months using MRI scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Privé Clairval
Marseille, 13273, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 3D camera make brain radiation safer and more precise?
- Pinpoint radiation may spare the brain in lung cancer that spreads
- Spinal fluid DNA test could personalize brain cancer therapy
- Focused radiation doses put to the test for large brain tumors
- Brain scan breakthrough: amino acid PET may solve a tricky diagnosis dilemma
- Spared brain region may shield memory during whole brain radiation